Related Experiment Video
Updated: May 24, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Pulmonary emboli from therapeutic sodium hyaluronate
Rajesh Bhagat1, Rosanna M Forteza, Clay B Calcote
1Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, GV Sonny Montgomery Veterans Affairs Medical Center, and University of Mississippi Medical Center, Jackson, Mississippi 39216-4505, USA. tdwyer@umc.edu
Sodium hyaluronate (HA) injections can cause pulmonary emboli, leading to breathing difficulties. Pulmonary function tests can help detect these unusual emboli when other methods fail.
Area of Science:
- Pulmonary Medicine
- Rheumatology
- Pathology
Background:
- Hyaluronate (HA) is commonly used for osteoarthritis treatment.
- Adverse events following HA injections are typically localized.
Observation:
- A patient developed shortness of breath and pleuritic pain post-bilateral knee HA injections.
- Initial investigations for deep vein thrombosis and pulmonary embolism were negative.
- Radiological findings included peripheral ground glass opacities and septal lines.
Findings:
- Lung biopsy revealed hyaluronate (HA) and fibrin emboli in pulmonary arteries and lymphatic vessels.
- A bone marrow embolus was also identified.
- Pulmonary function tests showed reduced diffusing capacity of the lung for carbon monoxide (D(LCO)).
Implications:
- This is the first report of pulmonary emboli caused by therapeutic hyaluronate (HA) injections.
- Pulmonary function tests can aid in diagnosing pulmonary emboli in atypical cases.
- Highlights the importance of considering non-thrombotic causes for pulmonary symptoms post-HA injection.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Pulmonary Embolism III: Nursing Management
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
